SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
XOMA (US) LLC Initiates Safety and Efficacy Study of Gevokizumab in Patients With Non-Infectious Uveitis Currently Controlled by Systemic Treatment